The recent saga of cardiovascular disease and safety of oral contraceptives

By Edwards R.  

Human Reproduction Update, Vol. 5, Iss. 6, 1999-12 ,pp. : 565-620

Oxford University Press

Access to resources Recommend Favorite

Combined oral contraceptives in the treatment of polycystic ovary syndrome

By Vrbíková J.  

Human Reproduction Update, Vol. 11, Iss. 3, 2005-05 ,pp. : 277-291

Oxford University Press

Access to resources Recommend Favorite

Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease

By Weng Yunqi   Yao Jian   Sparks Sawyer   Wang Kevin Yueju  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-02 ,pp. : 523-523

MDPI

Access to resources Recommend Favorite

Invasion Strategies of the Oral Pathogen Porphyromonas gingivalis: Implications for Cardiovascular Disease

By  

Invasion and Metastasis, Vol. 18, Iss. 2, 1999-06 ,pp. : 57-69

Karger

Access to resources Recommend Favorite

Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogen in women using oral contraception and hormone replacement therapy

By Crosignani P.   La Vecchia C.   Capri Workshop Group E.  

Human Reproduction Update, Vol. 5, Iss. 6, 1999-12 ,pp. : 681-687

Oxford University Press

Access to resources Recommend Favorite